bpc-157 risks research This doesn't mean is side-effect-free. But it does add to the safety signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out BPC-157: Experimental Peptide Creates Risk

The risk is much higher in men and women with gonadal dysgenesis, specially forms that arise from early gonadal differentiation defects, such as mutations in SRY and WT1, than in individuals with ovotesticular DSD or with hormone synthesis or action disorders (for example, androgen insensitivity) [168,169,170]

How you store the reconstituted solution will determine how long it remains viable for your research

(2018) Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer

Preclinical studies reflect that BPC 157 supports tissue repair by promoting angiogenesis

Pernicious Anaemia: Pernicious anaemia is a significant factor behind B12 deficiency